• A Biopharma Innovator's Wish List For President Trump

    STAT | In his first State of the Union address, the CEO of Alnylam Pharmaceuticals would like to hear President Trump address five key issues to foster the culture of innovation in the pharmaceutical industry.

    Jan 30, 2018

  • Will America Yield Its Position As The World’s Leader In Science And Technology?

    BostonGlobe | For the first time since World War II, America's primacy in science and technology is in jeopardy. Choices that the country makes today will determine whether it continues to reap the rewards that come from being at the cutting edge.

    Jan 29, 2018

  • Oxford Nanopore MinION Used To Produce Most Complete Human Genome

    Bio-IT World   A paper published today in Nature Biotechnology, reports Oxford Nanopore sequencing resulting in the most complete human genome ever assembled with a single technology.

    Jan 29, 2018

  • Genedata, Congenica, Nanome, And More: News From January 2018

    Bio-IT World | January featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Genedata, Congenica, Nanome, and more.

    Jan 29, 2018

  • Video: The Hyve Discusses Health Data Research Infrastructures, IoT In Webinar

    Bio-IT World | In a recent webinar, Kees Bochove of The Hyve delved into consent, GDPR, the healthcare professional’s role in infrastructure, FAIR principles, open source solutions, the future of wearables, and much more.

    Jan 26, 2018

  • The Cult Of DNA-centricity

    Forbes | All of biology lies in the genome, right? That's a premise of modern medicine: a disease-free utopia based on gene therapy and, soon, gene editing. But what if the real answers lie in your proteins? DNA-centric thinking is holding back the next wave of cures for diseases like Alzheimer's.

    Jan 25, 2018

  • BGI Increases Long-Read Sequencing Capacity With Purchase Of 10 PacBio Sequel Systems

    Bio-IT World Brief | BGI and Pacific Biosciences today announced an agreement by BGI Genomics to purchase an additional 10 Sequel Systems, significantly expanding the capacity for Single Molecule, Real-Time Sequencing for BGI’s global sequencing service business.

    Jan 25, 2018

  • VA Data And DOE Supercomputers Converge

    Bio-IT World | A joint initiative between the Department of Energy and the U.S. Department of Veterans Affairs is using supercomputers to collect genetic, military exposure, lifestyle, and health information about veterans that can be used to understand how genes affect health and illness.

    Jan 24, 2018

  • Why Celgene's Acquisition Of Juno Matters For Biotech And Investors

    Forbes | Celgene just acquired immunotherapy biotech Juno Therapeutics in a $9 billion dollar deal. The deal will allow Celgene to compete in a space already occupied by Novartis and Gilead as they vie for hegemony in a new field of oncology.

    Jan 23, 2018

  • Packing A Genome, Step-by-Step

    HHMI | For the first time, scientists can see in minute-time resolution how cells package chromosomes into highly condensed structures prior to cell division.

    Jan 19, 2018

  • CRISPR And Reddit: Doudna Hosts “Ask Me Anything” Session

    Bio-IT World | Jennifer Doudna hosted an “Ask Me Anything” session on Reddit with assistance from her colleagues at Doudna Lab and at the National Human Genome Research Institute. Topics from the session include CRISPR/Cas9 litigation, potential immunity to CRISPR, Designer Babies, and more.

    Jan 19, 2018

  • PacBio Outlook 2018

    Omics! Omics! | Keith Robison gives his take on PacBio's recent presentation at the JP Morgan Healthcare Conference.

    Jan 18, 2018

  • Why Gene Therapy Is No Longer A Pipe Dream

    Pacific Standard | After decades of disappointment, cures to once-incurable diseases seem within reach.

    Jan 18, 2018

  • Celgene In Talks To Buy Juno Therapeutics

    New York Business Journal | Celgene is looking to purchase Juno Therapeutics, just one week after it announced that it was taking over Impact Biomedicines in a $7 billion transaction.

    Jan 17, 2018

  • Has Bio-IT Soured On Cloud?

    Bio-IT World | Bio-IT has swung the gamut of opinions on cloud solutions. First wary, then warming, now, perhaps, pulling back. The inconsistency comes as use cases evolve and costs are closely watched. But there’s no denying that the cloud lets researchers do things they’ve never done before. The trick is finding the right balance.

    Jan 17, 2018

  • Howard Jacob Leaving HudsonAlpha For AbbVie

    Bio-IT World | Less than three years after leaving the Medical College of Wisconsin for the HudsonAlpha Institute in Huntsville, Alabama, Howard Jacob is starting today as the Vice President of the Genomic Research Center at AbbVie.

    Jan 16, 2018

  • DNA Sequencing Holds Some Promise For Treating Tumors

    NPR | Sequencing the DNA of cancer tumors to help pinpoint treatment is an emerging element of precision medicine. While patients and doctors alike want these tests, they often don't benefit patients.

    Jan 15, 2018

  • 23andMe CEO Goes Beyond “Wall Of A White Coat”

    Bio-IT World | Speaking at the 36th annual JP Morgan Healthcare Conference, 23andMe’s CEO and co-founder Anne Wojcicki reflected on the scope of the 23andMe’s dataset, especially as it pertains to healthcare and drug discovery.

    Jan 15, 2018

  • JP Morgan 2018 News Roundup

    Bio-IT World | The 36th annual JP Morgan Healthcare Conference was held this week in San Francisco, bringing together more than 400 companies to showcase their growth and innovation. Here are some of the highlights and announcements we’ve collected from the conference.

    Jan 12, 2018

  • Nonprofit Price For New Childhood Blindness Therapy 4X Too High

    STAT | Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.

    Jan 12, 2018